Christian Nehls

Dr. Christian Nehls

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2019 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
FBFlorian Bleibaum
Florian Bleibaum
ASAnselm Sommer
Anselm Sommer
MVMartin Veit
Martin Veit
BRBjörn Rabe
Björn Rabe
JAJörg Andrä
Jörg Andrä
KRKarina Reiss
Karina Reiss
Dysregulation of the disintegrin-metalloproteinase ADAM10 may contribute to the development of diseases including tumorigenesis and Alzheimer’s disease. The mechanisms underlying ADAM10 sheddase activation are incompletely understood. Here, we show that transient exposure of the negatively charged phospholipid phosphatidylserine (PS) is necessarily required. The soluble PS headgroup was found to act as competitive inhibitor of substrate cleavage. Overexpression of the Ca2+-dependent phospholipid scramblase Anoctamin-6 (ANO6) led to increased PS externalization and substrate release. Transfection with a constitutively active form of ANO6 resulted in maximum sheddase activity in the absence of any stimulus. Calcium-dependent ADAM10 activation could not be induced in lymphocytes of patients with Scott syndrome harbouring a missense mutation in ANO6. A putative PS-binding motif was identified in the conserved stalk region. Replacement of this motif resulted in strong reduction of sheddase activity. In conjunction with the recently described 3D structure of the ADAM10 extracellular domain, a model is advanced to explain how surface-exposed PS triggers ADAM10 sheddase function.

28 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ASAndra B. Schromm
Andra B. Schromm
LPLaura Paulowski
Laura Paulowski
YKYani Kaconis
Yani Kaconis
FKFranziska Kopp
Franziska Kopp
MKMax Koistinen
Max Koistinen
TGThomas Gutsmann
Thomas Gutsmann
Significance: Antibiotic resistance among clinically relevant bacteria presents an increasing threat and raises the urgent need for new compounds. Antimicrobial peptides and peptide antibiotics are potent membrane-active molecules and valuable prototypes for drug development. In gram-negative infections, killing of bacteria by antimicrobials is accompanied by the release of lipopolysaccharide (LPS), an endotoxin that causes severe hyperinflammation and pathology. We demonstrate how two medically relevant peptides, the cathelicidin LL-32 and polymyxin B, disarm endotoxins by peptide–LPS interaction. Furthermore, our studies reveal a mechanism of peptide-mediated immune control by acting on signaling domains of the immune cell membrane. Our results significantly enhance our understanding of how peptide antibiotics can regulate inflammation and will be important for their development and therapeutic use.

28 April 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
RJRavindra P. Jumde
Ravindra P. Jumde
MGMelissa Guardigni
Melissa Guardigni
RGRobin M. Gierse
Robin M. Gierse
AAAlaa Alhayek
Alaa Alhayek
DZDi Zhu
Di Zhu
AHAnna Hirsch
Anna Hirsch
Target-directed dynamic combinatorial chemistry (tdDCC) enables identification, as well as optimization of ligands for un(der)explored targets such as the anti-infective target 1-deoxy-D-xylulose-5-phosphate synthase (DXPS). We report the use of tdDCC to first identify and subsequently optimize binders/inhibitors of the anti-infective target DXPS. The initial hits were also optimized for their antibacterial activity against E. coli and M. tuberculosis during subsequent tdDCC runs. Using tdDCC, we were able to generate acylhydrazone-based inhibitors of DXPS. The tailored tdDCC runs also provided insights into the structure–activity relationship of this novel class of DXPS inhibitors. The competition tdDCC runs provided important information about the mode of inhibition of acylhydrazone-based inhibitors. This approach holds the potential to expedite the drug-discovery process and should be applicable to a range of biological targets.

27 June 2022 in Analytical Chemistry
Verified
Journal Article
Open access
KNKareem Al Nahas
Kareem Al Nahas
MFMarcus Fletcher
Marcus Fletcher
KHKatharine Hammond
Katharine Hammond
CNChristian Nehls
Christian Nehls
JCJehangir Cama
Jehangir Cama
UKUlrich F. Keyser
Ulrich F. Keyser
Host defense or antimicrobial peptides hold promise for providing new pipelines of effective antimicrobial agents. Their activity quantified against model phospholipid membranes is fundamental to a detailed understanding of their structure-activity relationships. However, classical characterization assays often lack the ability to achieve this insight. Leveraging a highly parallelized microfluidic platform for trapping and studying thousands of giant unilamellar vesicles, we conducted quantitative long-term microscopy studies to monitor the membrane-disruptive activity of archetypal antimicrobial peptides with a high spatiotemporal resolution. We described the modes of action of these peptides via measurements of the disruption of the vesicle population under the conditions of continuous peptide dosing using a range of concentrations and related the observed modes to the molecular activity mechanisms of these peptides. The study offers an effective approach for characterizing membrane-targeting antimicrobial agents in a standardized manner and for assigning specific modes of action to the corresponding antimicrobial mechanisms.

22 February 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
RMRita Müller
Rita Müller
AKAnnika König
Annika König
SGSabrina Groth
Sabrina Groth
RZRobert Zarnowski
Robert Zarnowski
CVCorissa Visser
Corissa Visser
Bernhard HubeBernhard Hube
Bernhard Hube
The opportunistic fungal pathogen Candida albicans damages host cells via its peptide toxin, candidalysin. Before secretion, candidalysin is embedded in a precursor protein, Ece1, which consists of a signal peptide, the precursor of candidalysin and seven non-candidalysin Ece1 peptides (NCEPs), and is found to be conserved in clinical isolates. Here we show that the Ece1 polyprotein does not resemble the usual precursor structure of peptide toxins. C. albicans cells are not susceptible to their own toxin, and single NCEPs adjacent to candidalysin are sufficient to prevent host cell toxicity. Using a series of Ece1 mutants, mass spectrometry and anti-candidalysin nanobodies, we show that NCEPs play a role in intracellular Ece1 folding and candidalysin secretion. Removal of single NCEPs or modifications of peptide sequences cause an unfolded protein response (UPR), which in turn inhibits hypha formation and pathogenicity in vitro. Our data indicate that the Ece1 precursor is not required to block premature pore-forming toxicity, but rather to prevent intracellular auto-aggregation of candidalysin sequences.

2 February 2022 in Membranes
Verified
Journal Article
Open access
PDF file
NRNiels Röckendorf
Niels Röckendorf
CNChristian Nehls
Christian Nehls
TGThomas Gutsmann
Thomas Gutsmann
A multitude of membrane active peptides exists that divides into subclasses, such as cell penetrating peptides (CPPs) capable to enter eukaryotic cells or antimicrobial peptides (AMPs) able to interact with prokaryotic cell envelops. Peptide membrane interactions arise from unique sequence motifs of the peptides that account for particular physicochemical properties. Membrane active peptides are mainly cationic, often primary or secondary amphipathic, and they interact with membranes depending on the composition of the bilayer lipids. Sequences of these peptides consist of short 5–30 amino acid sections derived from natural proteins or synthetic sources. Membrane active peptides can be designed using computational methods or can be identified in screenings of combinatorial libraries. This review focuses on strategies that were successfully applied to the design and optimization of membrane active peptides with respect to the fact that diverse features of successful peptide candidates are prerequisites for biomedical application. Not only membrane activity but also degradation stability in biological environments, propensity to induce resistances, and advantageous toxicological properties are crucial parameters that have to be considered in attempts to design useful membrane active peptides. Reliable assay systems to access the different biological characteristics of numerous membrane active peptides are essential tools for multi-objective peptide optimization.